,for, Item ID-
  • #1064517
  • Providers like you icon
  • Glaxo Smith Kline #58160095509

Menveo® Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL

MENVEO VACCINE, SDV 10-5MG/0.5ML (5/CT)

Glaxo Smith Kline 58160095509
Glaxo Smith Kline 58160095509
Glaxo Smith Kline 58160095509
Menveo® Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL
Menveo® Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL
Menveo® Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL
Compare

Features

  • MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age
  • MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration
  • More …
  Log In to Order
or
 View Alternatives

Product Specifications

Features
  • MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age
  • MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration
More Information

Professionals Also Viewed

    ,for, Item ID-
  • #1047522
  • Providers like you icon
  • Glaxo Smith Kline #58160097620
Bexsero® Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection 0.5 mL
  • BEXSERO is a vaccine indicated for active immunization to prevent inva …
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syrin …
    ,for, Item ID-
  • #944569
  • Providers like you icon
  • Pfizer (RSV Vaccines) #00005010005
Trumenba® Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection 0.5 mL
  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
  • 5 Syringes
    ,for, Item ID-
  • #944570
  • Providers like you icon
  • Pfizer (RSV Vaccines) #00005010010
Trumenba® Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection 0.5 mL
  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
  • 10 Syringes
    ,for, Item ID-
  • #1233496
  • Providers like you icon
  • Glaxo Smith Kline #58160082730
Menveo® Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL
  • MENVEO is a vaccine indicated for active immunization to prevent invas …
  • MENVEO does not prevent N. meningitidis serogroup B infections
  • Single-vial presentation
Compare Products (0) Clear Compare